Individual Stock News 1. GlaxoSmithKline (GSK.N)'s Allzaxel was approved in China for maintenance treatment of adult asthma patients. 2. JPMorgan Chase (JPM.N) approved CEO Jamie Dimon's $43 million compensation for 2025, compared to $39 million th

2026-01-23

Individual Stock News 1. GlaxoSmithKline (GSK.N)'s Allzaxel was approved in China for maintenance treatment of adult asthma patients. 2. JPMorgan Chase (JPM.N) approved CEO Jamie Dimon's $43 million compensation for 2025, compared to $39 million the previous year. 3. Alcoa (AA.N) reported Q4 2025 revenue of $3.449 billion, exceeding market expectations of $3.306 billion and compared to $3.486 billion in the same period last year. 4. Alcoa (AA.N): It expects total alumina production in its alumina business segment to be between 9.7 million and 9.9 million tons in 2026, with alumina shipments between 11.8 million and 12 million tons. 5. According to the Financial Times: Netflix (NFLX.O) co-CEOs stated that only a "very small number" of Warner Bros. Discovery (WBD) shares were submitted for a takeover bid to support Paramount's $108 billion hostile takeover offer for the entire company. 6. Intel (INTC.O) reported Q4 2025 revenue of $13.67 billion, exceeding market expectations of $13.37 billion and compared to $14.26 billion in the same period last year. 7. Sources revealed that Jensen Huang will visit China for the first time in 2026 to attend Nvidia's (NVDA.O) New Year's Eve party, but did not mention the H200. 8. Intel (INTC.O) expects Q1 revenue to be between $11.7 billion and $12.7 billion, with the midpoint lower than analysts' expectations of $12.6 billion. The company attributed the weak Q1 guidance primarily to supply shortages caused by manufacturing yield issues.